Related Experiment Video
Updated: Aug 24, 2026

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing (RIPiT-Seq)
Published on: July 10, 2019
Killing two birds with one RKIP
Reema Goel1, Joseph J Baldassare
1Department of Pharmacological and Physiological Sciences, St Louis University Medical School, Missouri 63104, USA.
Abstract:
Analysis of metastatic prostate cancers has identified the Raf kinase inhibitory protein (RKIP) as a suppressor of metastases. Previous studies demonstrated that RKIP binds to Raf-1 and prevents the activation of the extracellular regulated kinase (ERK) cascade. New work shows that phosphorylation of RKIP by protein kinase C disassociates RKIP from Raf-1 and stimulates its binding to, and inhibition of G-protein-coupled receptor kinase 2 (GRK2). This switching enhances signaling by activation of the ERK pathway and by decreased receptor desensitization.
Insights
The Raf kinase inhibitory protein (RKIP) suppresses prostate cancer metastasis by inhibiting Raf-1 and the ERK pathway. Protein kinase C phosphorylation causes RKIP to bind GRK2, enhancing ERK signaling and receptor desensitization.
Area of Science:
- Molecular biology
- Cancer research
- Signal transduction
Background:
- Metastatic prostate cancer analysis identified Raf kinase inhibitory protein (RKIP) as a metastasis suppressor.
- RKIP was previously shown to bind Raf-1, inhibiting the extracellular regulated kinase (ERK) cascade.
Purpose of the Study:
- To investigate the regulatory mechanism of RKIP in prostate cancer metastasis.
- To elucidate the role of RKIP phosphorylation by protein kinase C (PKC).
Main Methods:
- Biochemical assays to study protein-protein interactions.
- Analysis of signaling pathway activation (ERK pathway).
- Assessment of G-protein-coupled receptor kinase 2 (GRK2) activity.
Main Results:
- Phosphorylation of RKIP by PKC causes its dissociation from Raf-1.
- Phosphorylated RKIP binds to and inhibits GRK2.
- This molecular switch enhances ERK pathway activation and reduces receptor desensitization.
Conclusions:
- RKIP's function is regulated by phosphorylation, switching its binding partners.
- This mechanism contributes to the progression of metastatic prostate cancer.
- Targeting RKIP phosphorylation may offer therapeutic strategies for prostate cancer.
More Related Videos
13:34Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip
Published on: September 29, 2012
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
piRNA - Piwi-interacting RNAs
Electrolysis